Tuesday, November 17, 2026

Iboga

Ibogaine for Opioid Addiction : The Treatment Gaining Ground in 2026 and Where to Access It

Ibogaine has spent decades at the margins of addiction medicine, known primarily through underground networks and a small cluster of international clinics operating in countries where it is not...

Psychedelic Therapy in 2026: Where It Is Legal and How to Access It

Psychedelic therapy is not the same thing as taking a psychedelic substance on your own.  In legal, clinical, or regulated settings, it usually involves screening,...

Texas Prepares to Launch $50M Ibogaine Trial Program: A New Chapter in Psychedelic Medicine?

Texas is on the brink of launching the most ambitious state-backed psychedelic research initiative in U.S. history. A proposed $50 million public-private partnership aims...

Psychedelic Medicine Gains Momentum: Texas Pushes for Research Funding

Psychedelic research is reaching a turning point. Over the past decade, attitudes toward these substances have changed dramatically, shifting from stigma and controversy to...

DEA Boosts Psychedelic Production for Research into DMT and Psilocybin

The landscape of psychedelic research is rapidly evolving in the United States, with recent increases in legal production quotas for compounds like DMT. The...

Iboga/Ibogaine

Iboga is a shrub that is native to Gabon, Africa. Ibogaine is a psychedelic alkaloid that occurs naturally in the iboga shrub (Tabernanthe iboga),...